Océanie · Bourse & Finance · Stockhead

TrivarX’s brain cancer imaging pivot puts new CEO at centre of its reset

Publié par Stockhead · Australie il y a 2 h

TrivarX is preparing for a Phase I clinical trial to further understanding of the biophysical behaviour of its new Stabl-Im ... Read More The post TrivarX’s brain cancer imaging…

Lire l'article complet sur Stockhead Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stockhead.com.au)

TrivarX’s brain cancer imaging pivot puts new CEO at centre of its reset

À lire aussi

1 ASX dividend stock down 35% I'd buy right now

This building will cost more than $1 billion. What do we know about it?

Legendary hangover after Firmus’ $44b piss-up

Small Business: The silicone scar care company taking on wrinkles

Weekend Wrap: Wisetech shorts, Bears jump, Picks and shovels tumble

Part II – Navigating the Tricks of Uranium Investing

TrivarX’s brain cancer imaging pivot puts new CEO at centre of its reset

Partager

À lire aussi

1 ASX dividend stock down 35% I'd buy right now

This building will cost more than $1 billion. What do we know about it?

Legendary hangover after Firmus’ $44b piss-up

Small Business: The silicone scar care company taking on wrinkles

Weekend Wrap: Wisetech shorts, Bears jump, Picks and shovels tumble

Part II – Navigating the Tricks of Uranium Investing